Clinical Trials on Metastatic Castrate-Resistant Prostate Cancer (mCRPC) in United Kingdom
Total 708 results
-
University of Texas Southwestern Medical CenterCompletedmCRPC | Metastatic Castrate-resistant Prostate CancerUnited States
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
University of PennsylvaniaProstate Cancer FoundationRecruiting
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Sandy SrinivasWyeth is now a wholly owned subsidiary of Pfizer; American Society of Clinical... and other collaboratorsTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
BayerActive, not recruitingMetastatic Castrate Resistant Prostate Cancer (mCRPC)Spain, Korea, Republic of, United Kingdom, Australia, Hong Kong, Singapore, Taiwan, Lithuania, Russian Federation, Turkey, France, Israel, Czechia, Italy, Germany, Finland, Austria, Poland, Hungary
-
GenesisCare USADendreonCompletedCastrate Refractory Metastatic Prostate Cancer (mCRPC)United States
-
Bellicum PharmaceuticalsM.D. Anderson Cancer Center; The University of Texas Health Science Center,... and other collaboratorsCompletedCastrate Resistant Prostate Cancer (CRPC)United States
-
Promontory Therapeutics Inc.Active, not recruitingUrogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic Neoplasms | Advanced Solid Tumors | mCRPC | Metastatic Castrate-resistant Prostate Cancer | CRPC | PT-112United States, France
-
IpsenTerminatedMetastatic Castrate Resistant Prostate CancerFrance, Spain, Poland, Belgium, Germany, Italy, Denmark, Lithuania, United Kingdom, Czechia, Hungary
-
Barts & The London NHS TrustTerminatedCastrate Resistant Prostate CancerUnited Kingdom
-
National Cancer Institute (NCI)CompletedProstate Cancer | Metastatic Castrate Resistant Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.CompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
Exosome Diagnostics, Inc.Yale UniversitySuspendedMetastatic Castrate Resistant Prostate CancerUnited States
-
BayerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
The University of Texas Health Science Center at...WithdrawnMetastatic Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate Adenocarcinoma | Castrate Resistant Prostate CancerUnited States
-
Gilead SciencesTerminatedMetastatic Castrate-Resistant Prostate CancerUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLC; Prostate Cancer FoundationRecruitingProstate Cancer | Prostate Carcinoma | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate CancerUnited States
-
Celcuity IncRecruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Genital Diseases, Male | Prostatic Disease | mCRPC (Metastatic Castration-resistant Prostate Cancer) | Urogenital Diseases, MaleUnited States, France, Spain, United Kingdom
-
UNC Lineberger Comprehensive Cancer CenterWithdrawnMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Astellas Pharma IncTerminatedCastrate Resistant Prostate CancerBelgium, France, United Kingdom
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
Nuvation Bio Inc.WithdrawnProstate Cancer | Prostate Neoplasm | Cancer of the Prostate | Prostatic Cancer | Castrate Resistant Prostate Cancer | Cancer of Prostate | Castration Resistant Prostatic Cancer | Castration Resistant Prostatic NeoplasmsUnited States
-
UNC Lineberger Comprehensive Cancer CenterJohns Hopkins University; Memorial Sloan Kettering Cancer Center; United States... and other collaboratorsCompletedMetastatic Castrate-Resistant Prostate CancerUnited States
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Tracon Pharmaceuticals Inc.Janssen Pharmaceutica N.V., BelgiumCompletedMetastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, ProstateUnited States
-
University of Wisconsin, MadisonPfizerCompletedSolid Malignancies | Metastatic Castrate-resistant Prostate CancerUnited States
-
BeiGeneTerminatedMetastatic Castration-Resistant Prostate Cancer (mCRPC) | Homologous Recombination Deficiency (HRD)United States, Australia, Puerto Rico, Spain
-
Effector TherapeuticsTerminatedCastrate-resistant Prostate Cancer (CRPC)United States
-
Costantine AlbanyHoosier Cancer Research Network; Achieve Life SciencesTerminatedProstate Cancer | PSA | Metastatic Castrate-Resistant Prostate CancerUnited States, Canada
-
Alliance Foundation Trials, LLC.BayerRecruitingProstate Cancer | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Castrate Resistant Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...WithdrawnProstate Cancer | Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)United States
-
AmgenCompletedCastrate-resistant Prostate CancerUnited Kingdom, Czech Republic
-
Daniel VaenaCompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Novartis PharmaceuticalsTerminatedProstate Cancer | Castrate Resistant Prostate Cancer | Chemotherapy Naive Prostate CancerUnited States
-
Inmune Bio, Inc.RecruitingCancer | Metastatic Castration-resistant Prostate Cancer | mCRPCUnited States
-
University of OklahomaDendreonRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Tufts Medical CenterBayer; Ohio State University Comprehensive Cancer Center; Lahey Clinic; Henry Ford...Active, not recruitingMetastatic Castrate Resistant Prostate CancerUnited States
-
Institute of Cancer Research, United KingdomProstate Cancer UKRecruitingCastration-resistant Prostate Cancer | Metastatic Prostate CancerUnited Kingdom
-
AstraZenecaCompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Prostate Oncology Specialists, Inc.CompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
Charles RyanNovartis PharmaceuticalsTerminatedCastrate-resistant Prostate CancerUnited States
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Australia, Germany, United States, Puerto Rico, Israel, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania, Chile, Czechia, Hungary, Italy, Sweden, Turkey, United Kingdom, Estonia, Ir... and more
-
University of ChicagoNorthShore University HealthSystemCompletedRecurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate CancerUnited States
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
The Christie NHS Foundation TrustAstraZenecaCompletedMetastatic Castration Resistant Prostate CancerUnited Kingdom